当前位置:首页 - 行情中心 - 华兰疫苗(301207) - 财务分析

华兰疫苗

(301207)

  

流通市值:30.01亿  总市值:127.68亿
流通股本:1.41亿   总股本:6.00亿

华兰疫苗(301207)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.39亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益630721.17万元,未分配利润250033.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产780917.65万元,负债150196.48万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入34,222,695.92,410,428,457.21,718,267,831.09149,603,691.12
营业总成本53,561,895.091,407,172,971.751,047,980,586.15127,326,038.11
营业利润43,492,572.961,010,057,252.69737,508,632.46126,181,356.24
利润总额43,308,324.061,006,881,116.83734,927,835.53124,449,642.76
净利润38,589,463.38859,968,598.42629,714,837.48108,219,740.04
其他综合收益----
综合收益总额38,589,463.38859,968,598.42629,714,837.48108,219,740.04
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计5,313,164,810.945,226,815,305.375,041,192,871.314,005,190,983.63
非流动资产合计2,496,011,654.642,768,502,991.842,766,676,535.222,785,786,395.49
资产总计7,809,176,465.587,995,318,297.217,807,869,406.536,790,977,379.12
流动负债合计1,457,039,828.721,685,582,716.091,733,667,053.081,247,850,966.2
非流动负债合计44,924,930.1346,643,654.746,308,836.9843,929,777.07
负债合计1,501,964,758.851,732,226,370.791,779,975,890.061,291,780,743.27
归属于母公司股东权益合计6,307,211,706.736,263,091,926.426,027,893,516.475,499,196,635.85
股东权益合计6,307,211,706.736,263,091,926.426,027,893,516.475,499,196,635.85
负债和股东权益合计7,809,176,465.587,995,318,297.217,807,869,406.536,790,977,379.12
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计494,880,450.312,293,772,808.981,484,666,140.091,013,438,410.97
经营活动现金流出小计398,451,369.181,405,747,847.62995,998,125.77624,277,990.99
经营活动产生的现金流量净额96,429,081.13888,024,961.36488,668,014.32389,160,419.98
投资活动现金流入小计1,457,469,938.514,199,609,327.622,360,765,253.021,999,120,822.5
投资活动现金流出小计1,569,326,989.874,920,723,576.552,949,124,697.152,130,910,928.01
投资活动产生的现金流量净额-111,857,051.36-721,114,248.93-588,359,444.13-131,790,105.51
筹资活动现金流入小计0300,000,000300,000,000300,000,000
筹资活动现金流出小计1,516,666.67426,086,333.36424,569,666.69423,153,000.02
筹资活动产生的现金流量净额-1,516,666.67-126,086,333.36-124,569,666.69-123,153,000.02
汇率变动对现金及现金等价物的影响-45,054.57113,868.34--
现金及现金等价物净增加额-16,989,691.4740,938,247.41-224,261,096.5134,217,314.45
期末现金及现金等价物余额623,990,420.48640,980,111.95375,780,768.04734,259,178.99
最新报告期:2024-04-08
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
光大证券王明瑞1.812.202.602024-04-08
华泰证券代雯,张云逸,高初蕾1.792.242.802024-03-31
TOP↑